Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C26H27ClN2 |
| Molecular Weight | 402.959 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(C=C1)C(N2CCN(C\C=C\C3=CC=CC=C3)CC2)C4=CC=CC=C4
InChI
InChIKey=ZSQANMZWGKYDER-JXMROGBWSA-N
InChI=1S/C26H27ClN2/c27-25-15-13-24(14-16-25)26(23-11-5-2-6-12-23)29-20-18-28(19-21-29)17-7-10-22-8-3-1-4-9-22/h1-16,26H,17-21H2/b10-7+
| Molecular Formula | C26H27ClN2 |
| Molecular Weight | 402.959 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 1 |
| Optical Activity | ( + / - ) |
Clocinizine is an antihistamine derivative of diphenylmethylpiperazine. Clocinizine is a competitive and reversible H1 receptor antagonist. The drug is marketed in Spain under tradename Senioral in combination with phenylpropanolamine for temporary relief of nasal congestion in colds, rhinitis, and sinusitis.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:14:33 UTC 2023
by
admin
on
Fri Dec 15 16:14:33 UTC 2023
|
| Record UNII |
8HQJ711KH8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C77435
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
8HQJ711KH8
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
SUB06685MIG
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
CHEMBL2104069
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
688
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
DTXSID601027146
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
Clocinizine
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
298-55-5
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
5375618
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
1599
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
m3632
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000084305
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | |||
|
402583
Created by
admin on Fri Dec 15 16:14:33 UTC 2023 , Edited by admin on Fri Dec 15 16:14:33 UTC 2023
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
